Clinical relevance of detectable HCV RNA in the context of direct acting antivirals.

Files in this item

Icon
Name: KOS_ClinicalSV2012.pdf
Size: 186.6Kb
Format: PDF
Description: Submitted Version
View/Open

Clinical relevance of detectable HCV RNA in the context of direct acting antivirals.

O'Sullivan, Kathleen; Levis, John; Hegarty, Kevin G.; Crosbie, Orla; Kenny-Walsh, Elizabeth; Fanning, Liam J.
Date: 2012-07-14
Copyright: © 2012 by the American Association for the Study of Liver Diseases. This is the pre-peer reviewed version of the following article: O’Sullivan et al. (2013), Clinical relevance of detectable hepatitis C virus RNA in the context of direct-acting antivirals. Hepatology, 57: 855–856, which has been published in final form at doi:10.1002/hep.25942. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Citation: O'Sullivan, K., Levis, J., Hegarty, K., Crosbie, O., Kenny-Walsh, E. and Fanning, L. J. (2013), Clinical relevance of detectable hepatitis C virus RNA in the context of direct-acting antivirals. Hepatology, 57, pp. 855–856. http://dx.doi.org/10.1002/hep.25942
Published Version: 10.1002/hep.25942

Show full item record

This item appears in the following Collection(s)

This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement